DOLLY PHAM: Open Payments
NPI 1487386017 · PASADENA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$481 in 7 payments from 4 companies in 2025. Trend: 2023 $8,916 · 2024 $153 · 2025 $481
Food & beverage: $481
| Company | Payments | Amount |
|---|---|---|
| Eisai Inc. | 3 | $269 |
| Alexion Pharmaceuticals, Inc. | 2 | $143 |
| Janssen Biotech, Inc. | 1 | $37 |
| Lilly USA, LLC | 1 | $31 |
Products named: Leqembi, ULTOMIRIS, TREMFYA, KISUNLA.
Industry payments across CA — which companies pay providers there.
